Thromboembolic Events after the Coverage of Anterior Cerebral Artery with Flow Diversion: A Single Institution Series and Systematic Review.

Anterior Cerebral Artery Disability Flow diversion Thromboembolic complications

Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
14 May 2024
Historique:
received: 02 04 2024
accepted: 08 05 2024
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 16 5 2024
Statut: aheadofprint

Résumé

Advances in the use of flow diversion (FD) now extend to bifurcation aneurysms; herein, we compare thromboembolic events in patients with ICA aneurysms treated with and without exclusion of the ACA. Retrospective analysis of aneurysms in the terminal ICA treated with FD from 2013 to 2023 at a single-center. Procedures were classified according to the coverage at the origin of the ACA, and compared through bivariate-analysis. A review was also carried on PubMed, Web of Science, and EMBASE until April 2024, adhering to the PRISMA reporting guidelines. Ninety-five patients harboring 113 aneurysms treated in 102 procedures were evaluated. Fifty-eight were treated covering the ACA origin. Dual antiplatelet regimens included aspirin-clopidogrel (50%), aspirin-ticagrelor (44.1%), and aspirin-prasugrel (4.9%). Thromboembolic events occurred in six patients (5.9%), presenting with large vessel occlusion of the ICA, but without reaching statistical difference in the two treated cohorts (p=0.46). At a median clinical follow-up of 5.95 months, there were no differences in the functional outcomes in the two groups (p=0.22). Contralateral angiographic runs post-treatment after covering the ACA origin demonstrated increase in the A1 (median: 0.45mm; IQR=0.4-1.2) and ICA diameter (median: 0.55mm; IQR=0.1-1.2). After pooling data from literature and our cohort, complete side branch occlusion after the coverage of ACA was seen in 25% of branches (95%CI=0.16-0.36), and thromboembolic events were observed after 3% (95%CI=0.01-0.04) of procedures. Thromboembolic events can occur in distal ICA aneurysms treated with FD, but no significant association was seen with covering the ACA origin.

Sections du résumé

BACKGROUND BACKGROUND
Advances in the use of flow diversion (FD) now extend to bifurcation aneurysms; herein, we compare thromboembolic events in patients with ICA aneurysms treated with and without exclusion of the ACA.
METHODS METHODS
Retrospective analysis of aneurysms in the terminal ICA treated with FD from 2013 to 2023 at a single-center. Procedures were classified according to the coverage at the origin of the ACA, and compared through bivariate-analysis. A review was also carried on PubMed, Web of Science, and EMBASE until April 2024, adhering to the PRISMA reporting guidelines.
RESULTS RESULTS
Ninety-five patients harboring 113 aneurysms treated in 102 procedures were evaluated. Fifty-eight were treated covering the ACA origin. Dual antiplatelet regimens included aspirin-clopidogrel (50%), aspirin-ticagrelor (44.1%), and aspirin-prasugrel (4.9%). Thromboembolic events occurred in six patients (5.9%), presenting with large vessel occlusion of the ICA, but without reaching statistical difference in the two treated cohorts (p=0.46). At a median clinical follow-up of 5.95 months, there were no differences in the functional outcomes in the two groups (p=0.22). Contralateral angiographic runs post-treatment after covering the ACA origin demonstrated increase in the A1 (median: 0.45mm; IQR=0.4-1.2) and ICA diameter (median: 0.55mm; IQR=0.1-1.2). After pooling data from literature and our cohort, complete side branch occlusion after the coverage of ACA was seen in 25% of branches (95%CI=0.16-0.36), and thromboembolic events were observed after 3% (95%CI=0.01-0.04) of procedures.
CONCLUSION CONCLUSIONS
Thromboembolic events can occur in distal ICA aneurysms treated with FD, but no significant association was seen with covering the ACA origin.

Identifiants

pubmed: 38754548
pii: S1878-8750(24)00794-0
doi: 10.1016/j.wneu.2024.05.041
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Felipe Ramirez-Velandia (F)

Neurosurgical Service, Beth Israel Deaconess Medical Center. Boston, MA, United States; Harvard Medical School. Boston, MA, United States. Electronic address: felipegolframirez@gmail.com.

Alejandro Enriquez-Marulanda (A)

Neurosurgical Service, Beth Israel Deaconess Medical Center. Boston, MA, United States; Harvard Medical School. Boston, MA, United States.

Michael Young (M)

Neurosurgical Service, Beth Israel Deaconess Medical Center. Boston, MA, United States.

Eduardo Orrego-González (E)

Neurosurgical Service, Beth Israel Deaconess Medical Center. Boston, MA, United States.

Jean Filo (J)

Neurosurgical Service, Beth Israel Deaconess Medical Center. Boston, MA, United States; Harvard Medical School. Boston, MA, United States.

Thomas B Fodor (TB)

Neurosurgical Service, Beth Israel Deaconess Medical Center. Boston, MA, United States; Harvard Medical School. Boston, MA, United States.

Daniel Sconzo (D)

Neurosurgical Service, Beth Israel Deaconess Medical Center. Boston, MA, United States.

Max Shutran (M)

Neurosurgical Service, Beth Israel Deaconess Medical Center. Boston, MA, United States.

Christopher S Ogilvy (CS)

Neurosurgical Service, Beth Israel Deaconess Medical Center. Boston, MA, United States.

Philipp Taussky (P)

Neurosurgical Service, Beth Israel Deaconess Medical Center. Boston, MA, United States.

Classifications MeSH